Search research articles
Contact Us
Filters
Showing results (221-230 of 313) with videos related to
Page
of 32
Sort By:
Plos One
|
March 19, 2015
Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemia
Francesco Maura, Laura Mosca, Sonia Fabris, et al.
American Journal of Hematology
|
July 24, 2019
Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients
Irit Avivi, Yael C Cohen, Anna Suska, et al.
British Journal of Haematology
|
July 3, 2026
Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience
Andrea Duminuco, Dario Leotta, Alessandro Allegra, et al.
Non-Coding RNA
|
September 23, 2024
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study
Ennio Nano, Francesco Reggiani, Adriana Agnese Amaro, et al.
American Journal of Hematology
|
August 12, 2020
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies
Marzia Varettoni, Angela Ferrari, Anna M Frustaci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 12, 2014
microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters
Massimo Negrini, Giovanna Cutrona, Cristian Bassi, et al.
Leukemia & Lymphoma
|
February 5, 2015
Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia
Alessandra Tedeschi, Paola Picardi, Simone Ferrero, et al.
Cancers
|
November 8, 2019
Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis
Francesca Bonello, Stefano Pulini, Stelvio Ballanti, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 27, 2025
Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. <i>Pharmaceuticals</i> 2025, <i>18</i>, 595
Nicola Sgherza, Olga Battisti, Paola Curci, et al.
Leukemia & Lymphoma
|
April 11, 2015
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia
Francesco Maura, Giovanna Cutrona, Laura Mosca, et al.
Page
of 32
Search research articles
Search
Showing results (221-230 of 313) with videos related to
Sort By:
Page
of 32
Plos One
|
March 19, 2015
Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemia
Francesco Maura, Laura Mosca, Sonia Fabris, et al.
American Journal of Hematology
|
July 24, 2019
Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients
Irit Avivi, Yael C Cohen, Anna Suska, et al.
British Journal of Haematology
|
July 3, 2026
Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience
Andrea Duminuco, Dario Leotta, Alessandro Allegra, et al.
Non-Coding RNA
|
September 23, 2024
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study
Ennio Nano, Francesco Reggiani, Adriana Agnese Amaro, et al.
American Journal of Hematology
|
August 12, 2020
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies
Marzia Varettoni, Angela Ferrari, Anna M Frustaci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 12, 2014
microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters
Massimo Negrini, Giovanna Cutrona, Cristian Bassi, et al.
Leukemia & Lymphoma
|
February 5, 2015
Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia
Alessandra Tedeschi, Paola Picardi, Simone Ferrero, et al.
Cancers
|
November 8, 2019
Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis
Francesca Bonello, Stefano Pulini, Stelvio Ballanti, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 27, 2025
Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. <i>Pharmaceuticals</i> 2025, <i>18</i>, 595
Nicola Sgherza, Olga Battisti, Paola Curci, et al.
Leukemia & Lymphoma
|
April 11, 2015
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia
Francesco Maura, Giovanna Cutrona, Laura Mosca, et al.
Page
of 32